0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Altered oral microbiome, but normal human papilloma virus prevalence in cartilage-hair hypoplasia patients

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Cartilage-hair hypoplasia (CHH) is a rare syndromic immunodeficiency with metaphyseal chondrodysplasia and increased risk of malignancy. In this cross-sectional observational study, we examined HPV status and oral microbiome in individuals with CHH. Oral brush samples were collected from 20 individuals with CHH (aged 5–59 years) and 41 controls (1–69 years). Alpha HPVs (43 types) were tested by nested PCR followed by bead-based probe hybridization. Separately, beta-, gamma-, mu- and nu- HPV types were investigated, and a genome-based bacterial microbiome sequencing was performed.

          Results

          We found a similar alpha HPV prevalence in individuals with CHH (45%) and controls (36%). The HPV types of individuals with CHH were HPV-16 (25%), 27, 28, and 78, and of controls HPV-3, 16 (21%), 27, and 61. Beta HPV positivity and combined beta/gamma/mu/nu prevalence was detected in 11% and 11% of individuals with CHH and in 5% and 3% of the controls, respectively. Individuals with CHH differed from the controls in bacterial microbiota diversity, richness, and in microbial composition. Individuals with CHH had lower abundance of species Mitsuokella sp000469545, Parascardovia denticolens, Propionibacterium acidifaciens, UMGS1907 sp004151455, Salinicola halophilus, Haemophilus_A paraphrohaemolyticus, Fusobacterium massiliense , and Veillonella parvula, and higher abundance of Slackia exigua.

          Conclusions

          Individuals with CHH exhibit similar prevalence of HPV DNA but different bacterial microbiota on their oral mucosa compared to healthy controls. This may partly explain the previously observed high prevalence of oral diseases in CHH, and regular oral examination is warranted.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13023-024-03164-3.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

          Much of biomedical research is observational. The reporting of such research is often inadequate, which hampers the assessment of its strengths and weaknesses and of a study's generalizability. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Initiative developed recommendations on what should be included in an accurate and complete report of an observational study. We defined the scope of the recommendations to cover three main study designs: cohort, case-control, and cross-sectional studies. We convened a 2-day workshop in September 2004, with methodologists, researchers, and journal editors to draft a checklist of items. This list was subsequently revised during several meetings of the coordinating group and in e-mail discussions with the larger group of STROBE contributors, taking into account empirical evidence and methodological considerations. The workshop and the subsequent iterative process of consultation and revision resulted in a checklist of 22 items (the STROBE Statement) that relate to the title, abstract, introduction, methods, results, and discussion sections of articles. Eighteen items are common to all three study designs and four are specific for cohort, case-control, or cross-sectional studies. A detailed Explanation and Elaboration document is published separately and is freely available on the web sites of PLoS Medicine, Annals of Internal Medicine, and Epidemiology. We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A simple salting out procedure for extracting DNA from human nucleated cells.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

              Infections with certain viruses, bacteria, and parasites have been identified as strong risk factors for specific cancers. An update of their respective contribution to the global burden of cancer is warranted. We considered infectious agents classified as carcinogenic to humans by the International Agency for Research on Cancer. We calculated their population attributable fraction worldwide and in eight geographical regions, using statistics on estimated cancer incidence in 2008. When associations were very strong, calculations were based on the prevalence of infection in cancer cases rather than in the general population. Estimates of infection prevalence and relative risk were extracted from published data. Of the 12·7 million new cancer cases that occurred in 2008, the population attributable fraction (PAF) for infectious agents was 16·1%, meaning that around 2 million new cancer cases were attributable to infections. This fraction was higher in less developed countries (22·9%) than in more developed countries (7·4%), and varied from 3·3% in Australia and New Zealand to 32·7% in sub-Saharan Africa. Helicobacter pylori, hepatitis B and C viruses, and human papillomaviruses were responsible for 1·9 million cases, mainly gastric, liver, and cervix uteri cancers. In women, cervix uteri cancer accounted for about half of the infection-related burden of cancer; in men, liver and gastric cancers accounted for more than 80%. Around 30% of infection-attributable cases occur in people younger than 50 years. Around 2 million cancer cases each year are caused by infectious agents. Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide. Fondation Innovations en Infectiologie (FINOVI) and the Bill & Melinda Gates Foundation (BMGF). Copyright © 2012 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                heidi.arponen@helsinki.fi
                Journal
                Orphanet J Rare Dis
                Orphanet J Rare Dis
                Orphanet Journal of Rare Diseases
                BioMed Central (London )
                1750-1172
                18 April 2024
                18 April 2024
                2024
                : 19
                : 169
                Affiliations
                [1 ]GRID grid.7737.4, ISNI 0000 0004 0410 2071, Department of Oral and Maxillofacial Diseases, Helsinki University Hospital Head and Neck Center, , University of Helsinki, ; Haartmaninkatu 1, Helsinki, Finland
                [2 ]GRID grid.15485.3d, ISNI 0000 0000 9950 5666, Pediatric Research Center, , Children’s Hospital, University of Helsinki, Helsinki University Hospital, ; Helsinki, Finland
                [3 ]Western Uusimaa Wellbeing Services County, Espoo, Finland
                [4 ]Institute of Biomedicine, University of Turku, ( https://ror.org/05vghhr25) Turku, Finland
                [5 ]Clinical Microbiology, Turku University Hospital, ( https://ror.org/05dbzj528) Turku, Finland
                [6 ]National Reference Centre for Papilloma- and Polyomaviruses, Institute of Virology, Faculty of Medicine, University Hospital Cologne, ( https://ror.org/05mxhda18) Cologne, Germany
                [7 ]Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, ( https://ror.org/040af2s02) Helsinki, Finland
                [8 ]GRID grid.428673.c, ISNI 0000 0004 0409 6302, Folkhälsan Research Center, ; Helsinki, Finland
                [9 ]GRID grid.24381.3c, ISNI 0000 0000 9241 5705, Department of Molecular Medicine and Surgery, Karolinska Institutet and Clinical Genetics, , Karolinska University Hospital, ; Stockholm, Sweden
                [10 ]Department of Pathology, HUSLAB Diagnostics, Helsinki, Finland
                Author information
                http://orcid.org/0000-0003-0359-1486
                Article
                3164
                10.1186/s13023-024-03164-3
                11027548
                38637854
                25eda7ba-5da0-4300-811d-8cf6fd02aab0
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 22 October 2023
                : 30 March 2024
                Funding
                Funded by: University of Helsinki (including Helsinki University Central Hospital)
                Categories
                Research
                Custom metadata
                © Institut National de la Santé et de la Recherche Médicale (INSERM) 2024

                Infectious disease & Microbiology
                cartilage-hair hypoplasia,inborn errors of immunity,human papilloma virus,microbiome

                Comments

                Comment on this article